Editorial
Therapy option for early-stage lung cancer in nonsurgical patients
Translational Lung Cancer Research
2022;
11
(1)
:1-3
.
(26 January 2022)
Original Article
TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib
Translational Lung Cancer Research
2022;
11
(1)
:4-13
.
(26 January 2022)
Malignant thoracic lymph node classification with deep convolutional neural networks on real-time endobronchial ultrasound (EBUS) images
Translational Lung Cancer Research
2022;
11
(1)
:14-23
.
(26 January 2022)
A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
Translational Lung Cancer Research
2022;
11
(1)
:24-42
.
(26 January 2022)
Prognostic significance of procalcitonin in small cell lung cancer
Translational Lung Cancer Research
2022;
11
(1)
:43-52
.
(26 January 2022)
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
Translational Lung Cancer Research
2022;
11
(1)
:53-63
.
(26 January 2022)
The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma
Translational Lung Cancer Research
2022;
11
(1)
:64-74
.
(26 January 2022)
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(1)
:75-86
.
(26 January 2022)
Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study
Translational Lung Cancer Research
2022;
11
(1)
:87-99
.
(26 January 2022)
iMDT Corner
High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report
Translational Lung Cancer Research
2022;
11
(1)
:100-110
.
(26 January 2022)
Case Report
Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report
Translational Lung Cancer Research
2022;
11
(1)
:111-116
.
(26 January 2022)
Editorial Commentary
Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021
Translational Lung Cancer Research
2022;
11
(1)
:117-121
.
(26 January 2022)
Letter to the Editor
Smoking signature as a biomarker for immunotherapy
Translational Lung Cancer Research
2022;
11
(1)
:122-123
.
(26 January 2022)
Implementation of smoking signature as an improved biomarker predicting the response to immunotherapy
Translational Lung Cancer Research
2022;
11
(1)
:124-125
.
(26 January 2022)
